Indrayani Biotech Ltd.BSE: INDRANIB

Indrayani Biotech Ltd. Press Release Sep 16 2025

· Issued by Indrayani Biotech Ltd. via BSE India

Filed with BSE ·

On 6ix: 6ix.com/news/indrayani-biotech-ltd-press-release-sep-16-2025

The Company''s Wholly owned subsidiary, IBL Investment Limited, has received approval from SEBI for Category II Alternate Investment Fund Registration

View Attachment

6ix hasn’t read this filing yet.

Indrayani Biotech Ltd. on 6ix

Earlier from Indrayani Biotech

Later from Indrayani Biotech

All Indrayani Biotech news releases